POCT Market in US 2023-2027

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $2,500	138 Pages	TechNavio	July, 2023	INF18150549

Best Price Guarantee
Price	from $2,500
Length	138 Pages
Publisher	TechNavio
Published Date	July, 2023
SKU	INF18150549

POCT Market In US 2023-2027

The POCT market in US is forecasted to grow by USD 8514.52 mn during 2022-2027, accelerating at a CAGR of 8.65% during the forecast period. The report on the POCT market in US provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing prevalence of chronic diseases, rising awareness regarding portable and low-cost self-testing devices, and rising number of clia-waived POCT.

Technavio's POCT market in US is segmented as below:

By Type

OTC testing
Prescription-based testing

By Application

Blood glucose testing
Infectious diseases testing
Cardiac markers testing
Pregnancy and fertility testing
Others

This study identifies the technological advancements in POCT devices as one of the prime reasons driving the POCT market in US growth during the next few years. Also, rise in adoption of personalized medicine and POCT with multiplexing capabilities will lead to sizable demand in the market.

The report on the POCT market in US covers the following areas:

POCT market sizing in US
POCT market forecast in US
POCT market industry analysis in US

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POCT market in US vendors that include Abbott Laboratories, ACON Laboratories Inc., Becton Dickinson and Co., Bio Rad Laboratories Inc., Boditech Med Inc., Cardinal Health Inc., Chembio Diagnostics Inc., Danaher Corp., ELITechGroup SAS, F. Hoffmann La Roche Ltd., Heska Corp., iAssay Inc., Johnson and Johnson Services Inc., Nova Biomedical Corp., OraSure Technologies Inc., Phamatech Inc., Princeton BioMeditech Corp., QuidelOrtho Corp., Sekisui Chemical Co. Ltd., Trivida Health Inc., Zoetis Inc., and Quest Diagnostics Inc.. Also, the POCT market in US analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

1 Executive Summary: 1.1 Market overview; Exhibit 01: Executive Summary - Chart on Market Overview; Exhibit 02: Executive Summary - Data Table on Market Overview; Exhibit 03: Executive Summary - Chart on Country Market Characteristics; Exhibit 04: Executive Summary - Chart on Market Segmentation by Type; Exhibit 05: Executive Summary - Chart on Market Segmentation by Application; Exhibit 06: Executive Summary - Chart on Vendor Market Positioning
2 Market Landscape: 2.1 Market ecosystem; Exhibit 07: Parent market; Exhibit 08: Market Characteristics
3 Market Sizing: 3.1 Market definition; Exhibit 09: Offerings of vendors included in the market definition; 3.2 Market segment analysis; Exhibit 10: Market segments; 3.3 Market size 2022; 3.4 Market outlook: Forecast for 2022-2027; Exhibit 11: Chart on US - Market size and forecast 2022-2027 ($ billion); Exhibit 12: Data Table on US - Market size and forecast 2022-2027 ($ billion); Exhibit 13: Chart on US: Year-over-year growth 2022-2027 (%); Exhibit 14: Data Table on US: Year-over-year growth 2022-2027 (%)
4 Historic Market Size: 4.1 POCT market in US 2017 - 2021; Exhibit 15: Historic Market Size - Data Table on poct market in US 2017 - 2021 ($ billion); 4.2 Type Segment Analysis 2017 - 2021; Exhibit 16: Historic Market Size - Type Segment 2017 - 2021 ($ billion); 4.3 Application Segment Analysis 2017 - 2021; Exhibit 17: Historic Market Size - Application Segment 2017 - 2021 ($ billion)
5 Five Forces Analysis: 5.1 Five forces summary; Exhibit 18: Five forces analysis - Comparison between 2022 and 2027; 5.2 Bargaining power of buyers; Exhibit 19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; 5.3 Bargaining power of suppliers; Exhibit 20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; 5.4 Threat of new entrants; Exhibit 21: Threat of new entrants - Impact of key factors in 2022 and 2027; 5.5 Threat of substitutes; Exhibit 22: Threat of substitutes - Impact of key factors in 2022 and 2027; 5.6 Threat of rivalry; Exhibit 23: Threat of rivalry - Impact of key factors in 2022 and 2027; 5.7 Market condition; Exhibit 24: Chart on Market condition - Five forces 2022 and 2027
6 Market Segmentation by Type: 6.1 Market segments; Exhibit 25: Chart on Type - Market share 2022-2027 (%); Exhibit 26: Data Table on Type - Market share 2022-2027 (%); 6.2 Comparison by Type; Exhibit 27: Chart on Comparison by Type; Exhibit 28: Data Table on Comparison by Type; 6.3 OTC testing - Market size and forecast 2022-2027; Exhibit 29: Chart on OTC testing - Market size and forecast 2022-2027 ($ billion); Exhibit 30: Data Table on OTC testing - Market size and forecast 2022-2027 ($ billion); Exhibit 31: Chart on OTC testing - Year-over-year growth 2022-2027 (%); Exhibit 32: Data Table on OTC testing - Year-over-year growth 2022-2027 (%); 6.4 Prescription-based testing - Market size and forecast 2022-2027; Exhibit 33: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ billion); Exhibit 34: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ billion); Exhibit 35: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%); Exhibit 36: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%); 6.5 Market opportunity by Type; Exhibit 37: Market opportunity by Type ($ billion); Exhibit 38: Data Table on Market opportunity by Type ($ billion)
7 Market Segmentation by Application: 7.1 Market segments; Exhibit 39: Chart on Application - Market share 2022-2027 (%); Exhibit 40: Data Table on Application - Market share 2022-2027 (%); 7.2 Comparison by Application; Exhibit 41: Chart on Comparison by Application; Exhibit 42: Data Table on Comparison by Application; 7.3 Blood glucose testing - Market size and forecast 2022-2027; Exhibit 43: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ billion); Exhibit 44: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ billion); Exhibit 45: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%); Exhibit 46: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%); 7.4 Infectious diseases testing - Market size and forecast 2022-2027; Exhibit 47: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ billion); Exhibit 48: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ billion); Exhibit 49: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%); Exhibit 50: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%); 7.5 Cardiac markers testing - Market size and forecast 2022-2027; Exhibit 51: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ billion); Exhibit 52: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ billion); Exhibit 53: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%); Exhibit 54: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%); 7.6 Pregnancy and fertility testing - Market size and forecast 2022-2027; Exhibit 55: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ billion); Exhibit 56: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ billion); Exhibit 57: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); Exhibit 58: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); 7.7 Others - Market size and forecast 2022-2027; Exhibit 59: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 60: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibit 61: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibit 62: Data Table on Others - Year-over-year growth 2022-2027 (%); 7.8 Market opportunity by Application; Exhibit 63: Market opportunity by Application ($ billion); Exhibit 64: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape: 8.1 Customer landscape overview; Exhibit 65: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Drivers, Challenges, and Trends: 9.1 Market drivers; 9.2 Market challenges; 9.3 Impact of drivers and challenges; Exhibit 66: Impact of drivers and challenges in 2022 and 2027; 9.4 Market trends
10 Vendor Landscape: 10.1 Overview; 10.2 Vendor landscape; Exhibit 67: Overview on Criticality of inputs and Factors of differentiation; 10.3 Landscape disruption; Exhibit 68: Overview on factors of disruption; 10.4 Industry risks; Exhibit 69: Impact of key risks on business
11 Vendor Analysis: 11.1 Vendors covered; Exhibit 70: Vendors covered; 11.2 Market positioning of vendors; Exhibit 71: Matrix on vendor position and classification; 11.3 Abbott Laboratories; Exhibit 72: Abbott Laboratories - Overview; Exhibit 73: Abbott Laboratories - Business segments; Exhibit 74: Abbott Laboratories - Key news; Exhibit 75: Abbott Laboratories - Key offerings; Exhibit 76: Abbott Laboratories - Segment focus; 11.4 ACON Laboratories Inc.; Exhibit 77: ACON Laboratories Inc. - Overview; Exhibit 78: ACON Laboratories Inc. - Product / Service; Exhibit 79: ACON Laboratories Inc. - Key offerings; 11.5 Becton Dickinson and Co.; Exhibit 80: Becton Dickinson and Co. - Overview; Exhibit 81: Becton Dickinson and Co. - Business segments; Exhibit 82: Becton Dickinson and Co. - Key news; Exhibit 83: Becton Dickinson and Co. - Key offerings; Exhibit 84: Becton Dickinson and Co. - Segment focus; 11.6 Bio Rad Laboratories Inc.; Exhibit 85: Bio Rad Laboratories Inc. - Overview; Exhibit 86: Bio Rad Laboratories Inc. - Business segments; Exhibit 87: Bio Rad Laboratories Inc. - Key news; Exhibit 88: Bio Rad Laboratories Inc. - Key offerings; Exhibit 89: Bio Rad Laboratories Inc. - Segment focus; 11.7 Cardinal Health Inc.; Exhibit 90: Cardinal Health Inc. - Overview; Exhibit 91: Cardinal Health Inc. - Business segments; Exhibit 92: Cardinal Health Inc. - Key news; Exhibit 93: Cardinal Health Inc. - Key offerings; Exhibit 94: Cardinal Health Inc. - Segment focus; 11.8 Chembio Diagnostics Inc.; Exhibit 95: Chembio Diagnostics Inc. - Overview; Exhibit 96: Chembio Diagnostics Inc. - Product / Service; Exhibit 97: Chembio Diagnostics Inc. - Key offerings; 11.9 Danaher Corp.; Exhibit 98: Danaher Corp. - Overview; Exhibit 99: Danaher Corp. - Business segments; Exhibit 100: Danaher Corp. - Key news; Exhibit 101: Danaher Corp. - Key offerings; Exhibit 102: Danaher Corp. - Segment focus; 11.10 Johnson and Johnson Services Inc.; Exhibit 103: Johnson and Johnson Services Inc. - Overview; Exhibit 104: Johnson and Johnson Services Inc. - Business segments; Exhibit 105: Johnson and Johnson Services Inc. - Key news; Exhibit 106: Johnson and Johnson Services Inc. - Key offerings; Exhibit 107: Johnson and Johnson Services Inc. - Segment focus; 11.11 Nova Biomedical Corp.; Exhibit 108: Nova Biomedical Corp. - Overview; Exhibit 109: Nova Biomedical Corp. - Product / Service; Exhibit 110: Nova Biomedical Corp. - Key offerings; 11.12 OraSure Technologies Inc.; Exhibit 111: OraSure Technologies Inc. - Overview; Exhibit 112: OraSure Technologies Inc. - Business segments; Exhibit 113: OraSure Technologies Inc. - Key offerings; Exhibit 114: OraSure Technologies Inc. - Segment focus; 11.13 Princeton BioMeditech Corp.; Exhibit 115: Princeton BioMeditech Corp. - Overview; Exhibit 116: Princeton BioMeditech Corp. - Product / Service; Exhibit 117: Princeton BioMeditech Corp. - Key offerings; 11.14 Quest Diagnostics Inc.; Exhibit 118: Quest Diagnostics Inc. - Overview; Exhibit 119: Quest Diagnostics Inc. - Business segments; Exhibit 120: Quest Diagnostics Inc. - Key offerings; Exhibit 121: Quest Diagnostics Inc. - Segment focus; 11.15 QuidelOrtho Corp.; Exhibit 122: QuidelOrtho Corp. - Overview; Exhibit 123: QuidelOrtho Corp. - Product / Service; Exhibit 124: QuidelOrtho Corp. - Key offerings; 11.16 Trivida Health Inc.; Exhibit 125: Trivida Health Inc. - Overview; Exhibit 126: Trivida Health Inc. - Product / Service; Exhibit 127: Trivida Health Inc. - Key offerings; 11.17 Zoetis Inc.; Exhibit 128: Zoetis Inc. - Overview; Exhibit 129: Zoetis Inc. - Business segments; Exhibit 130: Zoetis Inc. - Key news; Exhibit 131: Zoetis Inc. - Key offerings; Exhibit 132: Zoetis Inc. - Segment focus
12 Appendix: 12.1 Scope of the report; 12.2 Inclusions and exclusions checklist; Exhibit 133: Inclusions checklist; Exhibit 134: Exclusions checklist; 12.3 Currency conversion rates for US$; Exhibit 135: Currency conversion rates for US$; 12.4 Research methodology; Exhibit 136: Research methodology; Exhibit 137: Validation techniques employed for market sizing; Exhibit 138: Information sources; 12.5 List of abbreviations; Exhibit 139: List of abbreviations
Exhibits:: Exhibits1: Executive Summary - Chart on Market Overview; Exhibits2: Executive Summary - Data Table on Market Overview; Exhibits3: Executive Summary - Chart on Country Market Characteristics; Exhibits4: Executive Summary - Chart on Market Segmentation by Type; Exhibits5: Executive Summary - Chart on Market Segmentation by Application; Exhibits6: Executive Summary - Chart on Vendor Market Positioning; Exhibits7: Parent market; Exhibits8: Market Characteristics; Exhibits9: Offerings of vendors included in the market definition; Exhibits10: Market segments; Exhibits11: Chart on US - Market size and forecast 2022-2027 ($ billion); Exhibits12: Data Table on US - Market size and forecast 2022-2027 ($ billion); Exhibits13: Chart on US: Year-over-year growth 2022-2027 (%); Exhibits14: Data Table on US: Year-over-year growth 2022-2027 (%); Exhibits15: Historic Market Size - Data Table on poct market in US 2017 - 2021 ($ billion); Exhibits16: Historic Market Size - Type Segment 2017 - 2021 ($ billion); Exhibits17: Historic Market Size - Application Segment 2017 - 2021 ($ billion); Exhibits18: Five forces analysis - Comparison between 2022 and 2027; Exhibits19: Chart on Bargaining power of buyers - Impact of key factors 2022 and 2027; Exhibits20: Bargaining power of suppliers - Impact of key factors in 2022 and 2027; Exhibits21: Threat of new entrants - Impact of key factors in 2022 and 2027; Exhibits22: Threat of substitutes - Impact of key factors in 2022 and 2027; Exhibits23: Threat of rivalry - Impact of key factors in 2022 and 2027; Exhibits24: Chart on Market condition - Five forces 2022 and 2027; Exhibits25: Chart on Type - Market share 2022-2027 (%); Exhibits26: Data Table on Type - Market share 2022-2027 (%); Exhibits27: Chart on Comparison by Type; Exhibits28: Data Table on Comparison by Type; Exhibits29: Chart on OTC testing - Market size and forecast 2022-2027 ($ billion); Exhibits30: Data Table on OTC testing - Market size and forecast 2022-2027 ($ billion); Exhibits31: Chart on OTC testing - Year-over-year growth 2022-2027 (%); Exhibits32: Data Table on OTC testing - Year-over-year growth 2022-2027 (%); Exhibits33: Chart on Prescription-based testing - Market size and forecast 2022-2027 ($ billion); Exhibits34: Data Table on Prescription-based testing - Market size and forecast 2022-2027 ($ billion); Exhibits35: Chart on Prescription-based testing - Year-over-year growth 2022-2027 (%); Exhibits36: Data Table on Prescription-based testing - Year-over-year growth 2022-2027 (%); Exhibits37: Market opportunity by Type ($ billion); Exhibits38: Data Table on Market opportunity by Type ($ billion); Exhibits39: Chart on Application - Market share 2022-2027 (%); Exhibits40: Data Table on Application - Market share 2022-2027 (%); Exhibits41: Chart on Comparison by Application; Exhibits42: Data Table on Comparison by Application; Exhibits43: Chart on Blood glucose testing - Market size and forecast 2022-2027 ($ billion); Exhibits44: Data Table on Blood glucose testing - Market size and forecast 2022-2027 ($ billion); Exhibits45: Chart on Blood glucose testing - Year-over-year growth 2022-2027 (%); Exhibits46: Data Table on Blood glucose testing - Year-over-year growth 2022-2027 (%); Exhibits47: Chart on Infectious diseases testing - Market size and forecast 2022-2027 ($ billion); Exhibits48: Data Table on Infectious diseases testing - Market size and forecast 2022-2027 ($ billion); Exhibits49: Chart on Infectious diseases testing - Year-over-year growth 2022-2027 (%); Exhibits50: Data Table on Infectious diseases testing - Year-over-year growth 2022-2027 (%); Exhibits51: Chart on Cardiac markers testing - Market size and forecast 2022-2027 ($ billion); Exhibits52: Data Table on Cardiac markers testing - Market size and forecast 2022-2027 ($ billion); Exhibits53: Chart on Cardiac markers testing - Year-over-year growth 2022-2027 (%); Exhibits54: Data Table on Cardiac markers testing - Year-over-year growth 2022-2027 (%); Exhibits55: Chart on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ billion); Exhibits56: Data Table on Pregnancy and fertility testing - Market size and forecast 2022-2027 ($ billion); Exhibits57: Chart on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); Exhibits58: Data Table on Pregnancy and fertility testing - Year-over-year growth 2022-2027 (%); Exhibits59: Chart on Others - Market size and forecast 2022-2027 ($ billion); Exhibits60: Data Table on Others - Market size and forecast 2022-2027 ($ billion); Exhibits61: Chart on Others - Year-over-year growth 2022-2027 (%); Exhibits62: Data Table on Others - Year-over-year growth 2022-2027 (%); Exhibits63: Market opportunity by Application ($ billion); Exhibits64: Data Table on Market opportunity by Application ($ billion); Exhibits65: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria; Exhibits66: Impact of drivers and challenges in 2022 and 2027; Exhibits67: Overview on Criticality of inputs and Factors of differentiation; Exhibits68: Overview on factors of disruption; Exhibits69: Impact of key risks on business; Exhibits70: Vendors covered; Exhibits71: Matrix on vendor position and classification; Exhibits72: Abbott Laboratories - Overview; Exhibits73: Abbott Laboratories - Business segments; Exhibits74: Abbott Laboratories - Key news; Exhibits75: Abbott Laboratories - Key offerings; Exhibits76: Abbott Laboratories - Segment focus; Exhibits77: ACON Laboratories Inc. - Overview; Exhibits78: ACON Laboratories Inc. - Product / Service; Exhibits79: ACON Laboratories Inc. - Key offerings; Exhibits80: Becton Dickinson and Co. - Overview; Exhibits81: Becton Dickinson and Co. - Business segments; Exhibits82: Becton Dickinson and Co. - Key news; Exhibits83: Becton Dickinson and Co. - Key offerings; Exhibits84: Becton Dickinson and Co. - Segment focus; Exhibits85: Bio Rad Laboratories Inc. - Overview; Exhibits86: Bio Rad Laboratories Inc. - Business segments; Exhibits87: Bio Rad Laboratories Inc. - Key news; Exhibits88: Bio Rad Laboratories Inc. - Key offerings; Exhibits89: Bio Rad Laboratories Inc. - Segment focus; Exhibits90: Cardinal Health Inc. - Overview; Exhibits91: Cardinal Health Inc. - Business segments; Exhibits92: Cardinal Health Inc. - Key news; Exhibits93: Cardinal Health Inc. - Key offerings; Exhibits94: Cardinal Health Inc. - Segment focus; Exhibits95: Chembio Diagnostics Inc. - Overview; Exhibits96: Chembio Diagnostics Inc. - Product / Service; Exhibits97: Chembio Diagnostics Inc. - Key offerings; Exhibits98: Danaher Corp. - Overview; Exhibits99: Danaher Corp. - Business segments; Exhibits100: Danaher Corp. - Key news; Exhibits101: Danaher Corp. - Key offerings; Exhibits102: Danaher Corp. - Segment focus; Exhibits103: Johnson and Johnson Services Inc. - Overview; Exhibits104: Johnson and Johnson Services Inc. - Business segments; Exhibits105: Johnson and Johnson Services Inc. - Key news; Exhibits106: Johnson and Johnson Services Inc. - Key offerings; Exhibits107: Johnson and Johnson Services Inc. - Segment focus; Exhibits108: Nova Biomedical Corp. - Overview; Exhibits109: Nova Biomedical Corp. - Product / Service; Exhibits110: Nova Biomedical Corp. - Key offerings; Exhibits111: OraSure Technologies Inc. - Overview; Exhibits112: OraSure Technologies Inc. - Business segments; Exhibits113: OraSure Technologies Inc. - Key offerings; Exhibits114: OraSure Technologies Inc. - Segment focus; Exhibits115: Princeton BioMeditech Corp. - Overview; Exhibits116: Princeton BioMeditech Corp. - Product / Service; Exhibits117: Princeton BioMeditech Corp. - Key offerings; Exhibits118: Quest Diagnostics Inc. - Overview; Exhibits119: Quest Diagnostics Inc. - Business segments; Exhibits120: Quest Diagnostics Inc. - Key offerings; Exhibits121: Quest Diagnostics Inc. - Segment focus; Exhibits122: QuidelOrtho Corp. - Overview; Exhibits123: QuidelOrtho Corp. - Product / Service; Exhibits124: QuidelOrtho Corp. - Key offerings; Exhibits125: Trivida Health Inc. - Overview; Exhibits126: Trivida Health Inc. - Product / Service; Exhibits127: Trivida Health Inc. - Key offerings; Exhibits128: Zoetis Inc. - Overview; Exhibits129: Zoetis Inc. - Business segments; Exhibits130: Zoetis Inc. - Key news; Exhibits131: Zoetis Inc. - Key offerings; Exhibits132: Zoetis Inc. - Segment focus; Exhibits133: Inclusions checklist; Exhibits134: Exclusions checklist; Exhibits135: Currency conversion rates for US$; Exhibits136: Research methodology; Exhibits137: Validation techniques employed for market sizing; Exhibits138: Information sources; Exhibits139: List of abbreviations